Published in Prostate Cancer Prostatic Dis on March 16, 2010
ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy. Am J Hum Genet (2013) 1.27
East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer (2011) 0.92
The effect of ethnicity and sexual preference on prostate-cancer-related quality of life. Nat Rev Urol (2012) 0.84
Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men. Eur Urol (2014) 0.83
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy. Pharmacogenomics J (2015) 0.81
EphB2 SNPs and sporadic prostate cancer risk in African American men. PLoS One (2011) 0.81
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res (2013) 0.80
Beyond the Ribosome: Extra-translational Functions of tRNA Fragments. Biomark Insights (2016) 0.78
Prostate Cancer Genetics: A Review. EJIFCC (2015) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Publication bias in clinical research. Lancet (1991) 22.85
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA (1992) 10.84
Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA (1998) 9.91
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A (1992) 3.28
A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease. Nucleic Acids Res (2003) 1.78
Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet (2000) 1.65
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev (2005) 1.37
Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett (2010) 1.35
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet (2001) 1.32
The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex. Int J Cancer (2003) 1.28
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res (2001) 1.26
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int (2002) 1.24
Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res (2001) 1.24
HPC2 variants and screen-detected prostate cancer. Am J Hum Genet (2001) 1.20
Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res (2001) 1.13
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst (2003) 1.10
Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am J Hum Genet (2002) 1.01
Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer (1997) 0.93
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate (2008) 0.91
Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate (2006) 0.90
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease. Br J Cancer (2002) 0.89
Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. J Hum Genet (2002) 0.89
ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Hum Genet (2002) 0.86
Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels. Future Oncol (2009) 0.85
HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer. Prostate (2004) 0.84
Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer Epidemiol Biomarkers Prev (2003) 0.84
Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci (2009) 0.82
Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. Int J Cancer (2003) 0.82
HPC2/ELAC2 gene variants associated with incident prostate cancer. J Hum Genet (2003) 0.81
Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer Res (2003) 0.80
Is dietary fat a risk factor for prostate cancer? J Natl Cancer Inst (1993) 0.80
An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb. BMJ (2000) 1.61
HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem (1999) 1.53
Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients. N Engl J Med (1981) 1.45
Emergency intubation for acutely ill and injured patients. Cochrane Database Syst Rev (2008) 1.31
Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic. Am J Hosp Pharm (1988) 0.99
Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factor-dependent PC12 cells. J Neurochem (2000) 0.91
Polypharmacy in an Australian teaching hospital. Preliminary analysis of prevalence, types of drugs and associations. Med J Aust (1986) 0.91
Release of the neuronal glycoprotein ICAM-5 in serum after hypoxic-ischemic injury. Ann Neurol (2000) 0.87
Berberine attenuates doxorubicin-induced cardiotoxicity in mice. J Int Med Res (2011) 0.86
Audit and scientific management of drug use in an Australian teaching hospital. Aust Health Rev (1982) 0.86
Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet Mol Res (2012) 0.84
Prospective audit of an aminoglycoside consultative service in a general hospital. Med J Aust (1992) 0.83
Successful substitution of rectal metronidazole administration for intravenous use. Lancet (1983) 0.83
Hospital pharmacy service provision in Australia--1998. Am J Health Syst Pharm (2000) 0.81
Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes. Med J Aust (1989) 0.81
Muscle infarction involving muscles of abdominal and thoracic walls in diabetes. Diabet Med (2005) 0.81
Dosage adjustment and clinical outcomes of long-term use of high-dose tobramycin in adult cystic fibrosis patients. J Antimicrob Chemother (1991) 0.81
Acarbose monotherapy and weight loss in Eastern and Western populations with hyperglycaemia: an ethnicity-specific meta-analysis. Int J Clin Pract (2014) 0.78
[The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia]. Hua Xi Yi Ke Da Xue Xue Bao (1991) 0.77
Drug rationing in a teaching hospital. BMJ (1994) 0.75
[Gigantism with low serum level of growth hormone: a case report]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 0.75
[Progress in research on adult patients with slowly progressive auto-immune diabetes]. Zhonghua Yi Xue Za Zhi (2001) 0.75
[The effects of intensive DMPA regimen in the treatment of Graves' ophthalmopathy]. Hua Xi Yi Ke Da Xue Xue Bao (1996) 0.75
A prospective study of the effects of oral probenecid on the pharmacokinetics of intravenous ticarcillin in patients with cystic fibrosis. J Antimicrob Chemother (1992) 0.75
Availability of drug assay results and dosage advice improves antiepileptic care in a specialist neurology outpatient clinic. Clin Exp Neurol (1985) 0.75
[Study on gastric motility and its relevant factors in type 2 diabetes]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 0.75
Computer-based prescription audit as a research, educational and management tool. Aust Health Rev (1984) 0.75
Doxorubicin-associated delayed ventricular fibrillation in acute promyelocytic leukemia. Acta Haematol (1983) 0.75